healthcare
Looking for the digital health tonic
Massive recent uptick in investment means 2019 is expected to reach an all-time high for digital health
BIVF, Gründerfonds Ruhr lead €12m series-A round for Abalos
Abalos Therapeutics is a biotechnology company focused on developing immuno-oncology therapeutics
Nordic Capital's Acino acquires Takeda's primary care portfolio
Coller Capital and Goldman Sachs acquired a stake in Acino in 2018 in a GP-led secondary transaction
VCs in £27m series-A for MiroBio
Advent Life Sciences, SR One, Oxford Science Innovation and Samsara Biocapital have invested
Inflexion to acquire Pharmaspectra
Inflexion Private Equity has taken a majority stake, drawing equity from its £250m fund
VCs in €40m series-D for Themis
US-based Farallon Capital, with Oslo- and Stockholm-based Hadean Ventures, led the round for Themis
LSP leads €10.5m series-D for Xeltis
Life Sciences Partners first invested in the medical devices company in 2014
Syncona, RA lead £100m series-B for Achilles
Syncona led a £13.2m funding round in 2016 for the cancer immunotherapy development company
Trilantic Europe's Oberberg makes two acquisitions
Trilantic's portfolio company, mental health clinic group Oberberg, bolts on Panorama and Jägerwinkel
Eurazeo, ADM in €60m round for M2I
Idinvest first invested in the pheromones and complex molecules producer in 2017
Equistone acquires Omnicare
Lincoln International led a sales process for the wholesale anti-cancer pharmaceuticals distributor
Nordic Capital shelves GHD GesundHeits sale - report
Nordic Capital has halted a sale process for homecare company GHD, which involved PAI and CD&R
EQT to sell Charleston
EQT acquired Charleston in 2014 and made nine bolt-on acquisitions throughout its holding period
Gimv, Sofinnova, Gilde exit Breath Therapeutics for €500m
Gimv and Sofinnova Partners co-led a 2017 €43.5m series-A for Breath Therapeutics, with participation from Gilde Helathcare
Waterland's Median Kliniken bolts on Eschenburg, Rhein-Reha
Waterland has owned Median Kliniken since 2014 and has now bolted on 21 companies
Paragon acquires Pro Optik
Optical retail chain Pro Optik is likely to be Paragon III fund's first acquisition
VCs sell Amal to Boehringer Ingelheim in €325m deal
Boehringer Ingelheim Venture Fund and High-Tech Gründerfonds provided seed funding for Amal in 2014
Waterland sells VivaNeo to Impilo portfolio company TFP
VivaNeo has closed 12 successful acquisitions during Waterland Private Equity's holding period
ArchiMed acquires Eurolyser and Eurolab
Transaction is part of a succession agreement that will see a co-founder of Eurolyser retire
ProA backs IPD
ProA has drawn equity from its ProA Capital Iberian Buyout Fund III, which closed on €475m
Highlander Partners acquires Ares Group
Cardiology care provider Ares Group is Highlander Partners' first acquisition in Romania
VCs invest €7m in CryoTherapeutics
Existing investors Creathor Ventures and Peppermint Venture Partners participate in the round
Charterhouse-backed Cooper bolts on Diepharmex
Geneva-headquartered Diepharmex manufactures products for hygiene and ear care such as ear sprays
ADC Therapeutics gathers $76m in series-E extension
Headquartered in Lausanne, ADC Therapeutics has raised $531m since its inception in 2012